IN8bio (INAB) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 7, 2026, to be held virtually for shareholders of record as of March 18, 2026.

• Shareholders will vote on director elections, auditor ratification, and an equity incentive plan.

Voting matters and shareholder proposals

• Election of two Class II directors, Peter Brandt and Corinne Epperly, to serve until the 2029 annual meeting.

• Ratification of CohnReznick LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Approval of the Amended and Restated 2026 Equity Incentive Plan.

Board of directors and corporate governance

• Two nominees for Class II director positions are presented for election, with terms extending to 2029.